![MyNeuroNews](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/144/normal/Screenshot_2019-07-30_at_09.20.34.png?1564474985)
Clinical Parameters to Predict Future Clinical Disease Activity After Treatment Change to Higher-Dose Subcutaneous Interferon Beta-1a From Other Platform Injectables in Patients With Relapsing-Remitting Multiple Sclerosis
MyNeuroNews,
Objective: To identify predictors of clinical disease activity after treatment change to higher-dose interferon beta-1a in…